Relay Therapeutics Inc is trading 5.1% down at $13.80 as a hotter-than-expected U.S. jobs report fuels concerns over rising interest rates and impacts high-growth sectors.
- The downward movement is linked to broad selling across biotech and growth shares rather than any new company-specific news or changes to guidance.
- The stock is experiencing a sharp pullback following its significant price spike observed on June 2, 2026.